Cite

HARVARD Citation

    Robertz, J. et al. (n.d.). Obinutuzumab in two patients suffering from immune‐mediated thrombotic thrombocytopenic purpura intolerant to rituximab. American journal of hematology. 94 (10), pp. E259-E261. [Online]. 
  
Back to record